Hepatotoxicity of an HIV protease inhibitor in dogs and rats

Toxicology and Applied Pharmacology

Volumn 146, Issue 1, 1997, Pages 40-52

  Grossman, Scott J ^a   Reinford, Neil ^a   Anderson, Charles ^a   Eydelloth, Ronald S ^a   Alberts, David W ^a   Smith, Peter F ^a   Patrick, Darryl H ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; L 689502; PROTEINASE INHIBITOR; TAUROURSODEOXYCHOLIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BILE FLOW; CHOLESTASIS; CONTROLLED STUDY; DOG; FEMALE; HISTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT;

ANIMALIA; CANIS FAMILIARIS;

EID: 0030930735     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8224     Document Type: Article

References (29)

1. Bradley S. E., Herz R. Permselectivity of biliary canalicular membrane in rats: Clearance probe analysis. Am. J. Physiol. 235:1978;E570-E576.
2. Connolly A. K., Price S. C., Connelly J. C., Hinton R. H. Early changes in bile duct lining cells and hepatocytes in rats treated with α-naphthylisothiocyanate. Toxicol. Appl. Pharmacol. 93:1988;208-219.
3. Forker E. L. Two sites of bile formation as determined by mannitol and erythritol clearance in the guinea pig. J. Clin. Invest. 46:1967;1189-1195.
4. Gumucio J. J., Valdivieso V. D. Studies on the mechanism of the ethynylestradiol impairment of bile flow and bile salt excretion in the rat. Gastroenterology. 61:1971;339-344.
5. Jaeschke H., Krell H., Pfaff E. No increase of biliary permeability in ethinylestradiol-treated rats. Gastroenterology. 85:1983;808-814.
6. Jaeschke H., Kress H., Pfaff E. Quantitative estimation of transcellular and paracellular pathways of biliary sucrose in isolated perfused rat liver. Biochem. J. 241:1987;635-640.
7. Jean P. A., Bailie M. B., Roth R. A. 1-Naphylisothiocyanate-induced elevation of biliary glutathione. Biochem. Pharmacol. 49:1995;197-202.
8. Kan K. S., Coleman R. 1-Naphthylisothiocyanate-induced permeability of hepatic tight junctions to proteins. Biochem. J. 238:1986;323-328.
9. Kanz M. F., Kaphalia L., Kaphalia B. S., Romagnoli E., Ansari G. A. S. Methylene dianiline: Acute toxicity and effects on biliary function. Toxicol. Appl. Pharmacol. 117:1992;88-97.
10. Kohl N. E., Emini E. A., Schleif W. A., Davis L. J., Heimbach J. C., Dixon R. A. F., Scolnick E. M., Sigal I. S. Active human immunodeficiency virus protease is required for viral infectivity. Proc. Natl. Acad. Sci. USA. 85:1988;4686-4690.
11. Kossor D. C., Meunier P. C., Handler J. A., Sozio R. S., Goldstein R. S. Temporal relationship of changes in hepatobiliary function and morphology in rats following α-naphthylisothiocyanate (ANIT) administration. Toxicol. Appl. Pharmacol. 119:1993;108-114.
12. Krell H., Höke H., Pfaff E. Development of intrahepatic cholestasis by α-naphthylisothiocyanate in rats. Gastroenterol. 82:1982;507-514.
13. Krell H., Metz J., Jaeschke H., Höke H., Pfaff E. Drug-induced intrahepatic cholestasis: Characterization of different pathomechanisms. Arch. Toxicol. 60:1987;124-130.
14. Leonard T. B., Popp J. A., Graichen M. E., Dent J. G. α-Naphthylisothiocyanate induced alterations in hepatic drug metabolizing enzymes and liver morphology: Implications concerning anticarcinogenesis. Carcinogenesis. 2:1981;473-482.
15. Lin J. H., Chen I., King J. Dose-dependent toxicokinetics of L-689,502, a potent human immunodeficiency virus protease inhibitor, in rats and dogs. J. Pharmacol. Exp. Ther. 263:1992;105-111.
16. Lock S., Lavigne J., Plaa G. L. The effect of α-naphthylisothiocyanate on bile secretion prior to and during the onset of cholestasis in the rat. Toxicol. Lett. 10:1982;427-435.
17. Loranger A., Tuchweber B., Gicquad C., St-Pierre S., Cote M. G. Toxicity of peptides of Amanita virosa mushrooms in mice. Fundam. Appl. Toxicol. 5:1985;1144-1152.
18. Loranger A., Barriault C., Yousef I. M., Tuchweber B. Structural and functional alterations of hepatocytes during transient phalloidin-induced cholestasis in the rat. Toxicol. Appl. Pharmacol. 137:1996;100-111.
19. Nutt R. F., Brady S. F., Darke P. L., Ciccarone T. M., Colton C. D., Nutt E. M., Rodkey J. A., Bennet C. D., Waxman L. H., Sigal I. S., Anderson P. S. Chemical synthesis and enzymatic activity of a 99-residue peptide with a sequence proposed for the human immunodeficiency virus protease. Proc. Natl. Acad. Sci. USA. 85:1988;7129-7133.
20. Phillips M. J., Oshio C., Miyairi M., Smith C. R. Intrahepatic cholestasis as a canalicular motility disorder. Evidence using cytochalasin. Lab. Invest. 48:1983;205-211.
21. Ratner L., Haseltine W., Patarca R., Livak K. J., Starcich B., Josephs S. F., Doran E. R., Rafalski J. A., Whitehorn E. A., Baumeister K., Ivanoff L., Petteway S. R., Pearson M. L., Lautenberger J. A., Papas T. S., Ghayeb J., Chang N. T., Gallo R. C., Wong-Staal F. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature. 313:1985;277-284.
22. Roberts N. A., Martin J. A., Kinchington D., Broadhurst A. V., Craig J. C., Duncan I. B., Galpin S. A., Handa B. K., Kay J., Krohn A., Lambert R. W., Merrett J. H., Mills J. S., Parkes K. E. B., Redshaw S., Ritchie A. J., Taylor D. L., Thomas G. J., Machin P. J. Rational design of peptide-based HIV proteinase inhibitors. Science. 248:1990;358-361.
23. Slikker W. Jr., Vore M., Bailey J. R., Meyers M., Montgomery C. Hepatotoxic effects of estradiol-17β-D. J. Pharmacol. Exp. Ther. 225:1983;138-143.
24. Slott P. A., Liu M. H., Tavoloni N. Origin, pattern and mechanism of bile duct proliferation following biliary obstruction in the rat. Gastroenterology. 99:1990;466-477.
25. Spivey J. R., Bronk S. F., Gores G. J. Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium. J. Clin. Invest. 92:1993;17-24.
26. Tavoloni N., Reed J. S., Hruban Z., Boyer J. L. Effect of chlorpromazine on hepatic perfusion and bile secretory function in the isolated perfused rat liver. J. Lab. Clin. Med. 94:1979;726-741.
27. ′phenyl substituents: X-ray crystal structure assisted design. J. Med. Chem. 35:1992;1685-1701.
28. Vore M., Hadd H., Slikker W. Jr. Ethynylestradiol-17β D-ring glucuronide conjugates are potent cholestatic agents in the rat. Life Sci. 32:1983;866-2993.
29. Wheeler H. O., Ross E. D., Bradley S. E. Canalicular bile production in dogs. Am. J. Physiol. 214:1968;866-874.